When stratifying the analysis by American Joint Committee on Cancer stage for lung cancer, interestingly, a modest difference in anti-IGFBP-2 antibody levels was observed between early cancers and advanced cancers in lung cancer. Here, IGFBP2 is linked to lung carcinoma.